MedTrace Logo

Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss

NCT00180778 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2024-02-26

No results posted yet for this study

Summary

Does the addition of steroids during the first trimester to the standard aspirin + heparin treatment reduce the miscarriage rates in women with antiphospholipid antibodies and recurrent first trimester miscarriage in those who had an unsuccessful pregnancy with aspirin + heparin?

Conditions

  • Antiphospholipid Syndrome

Interventions

DRUG

Low dose steroids

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Raj Rai, MRCOG · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2005-10-31
Completion
2005-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00180778 on ClinicalTrials.gov